161 related articles for article (PubMed ID: 34481829)
1. HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts.
Pipalia NH; Saad SZ; Subramanian K; Cross A; Al-Motawa A; Garg K; Blagg BSJ; Neckers L; Helquist P; Wiest O; Ory DS; Maxfield FR
J Lipid Res; 2021; 62():100114. PubMed ID: 34481829
[TBL] [Abstract][Full Text] [Related]
2. Individualized management of genetic diversity in Niemann-Pick C1 through modulation of the Hsp70 chaperone system.
Wang C; Scott SM; Sun S; Zhao P; Hutt DM; Shao H; Gestwicki JE; Balch WE
Hum Mol Genet; 2020 Jan; 29(1):1-19. PubMed ID: 31509197
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.
Subramanian K; Rauniyar N; Lavalleé-Adam M; Yates JR; Balch WE
Mol Cell Proteomics; 2017 Nov; 16(11):1938-1957. PubMed ID: 28860124
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.
Pipalia NH; Subramanian K; Mao S; Ralph H; Hutt DM; Scott SM; Balch WE; Maxfield FR
J Lipid Res; 2017 Apr; 58(4):695-708. PubMed ID: 28193631
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice.
Ashikawa H; Mogi H; Honda T; Nakamura H; Murayama T
Eur J Pharmacol; 2021 Apr; 896():173907. PubMed ID: 33503462
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.
Pipalia NH; Cosner CC; Huang A; Chatterjee A; Bourbon P; Farley N; Helquist P; Wiest O; Maxfield FR
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5620-5. PubMed ID: 21436030
[TBL] [Abstract][Full Text] [Related]
7. Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.
Subramanian K; Hutt DM; Scott SM; Gupta V; Mao S; Balch WE
J Biol Chem; 2020 Jun; 295(23):8017-8035. PubMed ID: 32354745
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum-associated degradation of Niemann-Pick C1: evidence for the role of heat shock proteins and identification of lysine residues that accept ubiquitin.
Nakasone N; Nakamura YS; Higaki K; Oumi N; Ohno K; Ninomiya H
J Biol Chem; 2014 Jul; 289(28):19714-25. PubMed ID: 24891511
[TBL] [Abstract][Full Text] [Related]
9. Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability.
Brogden G; Shammas H; Walters F; Maalouf K; Das AM; Naim HY; Rizk S
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204338
[TBL] [Abstract][Full Text] [Related]
10. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
Boadu E; Nelson RC; Francis GA
Biochim Biophys Acta; 2012 Mar; 1821(3):396-404. PubMed ID: 22179027
[TBL] [Abstract][Full Text] [Related]
11. Targeting defective sphingosine kinase 1 in Niemann-Pick type C disease with an activator mitigates cholesterol accumulation.
Newton J; Palladino END; Weigel C; Maceyka M; Gräler MH; Senkal CE; Enriz RD; Marvanova P; Jampilek J; Lima S; Milstien S; Spiegel S
J Biol Chem; 2020 Jul; 295(27):9121-9133. PubMed ID: 32385114
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein amplification improves cerebellar myelination in the Npc1
Gray J; Fernández-Suárez ME; Falah M; Smith D; Smith C; Kaya E; Palmer AM; Fog CK; Kirkegaard T; Platt FM
EBioMedicine; 2022 Dec; 86():104374. PubMed ID: 36455410
[TBL] [Abstract][Full Text] [Related]
13. Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding.
Gelsthorpe ME; Baumann N; Millard E; Gale SE; Langmade SJ; Schaffer JE; Ory DS
J Biol Chem; 2008 Mar; 283(13):8229-36. PubMed ID: 18216017
[TBL] [Abstract][Full Text] [Related]
14. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
[TBL] [Abstract][Full Text] [Related]
15. Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems.
Völkner C; Pantoom S; Liedtke M; Lukas J; Hermann A; Frech MJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159129
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage.
Ilnytska O; Lai K; Gorshkov K; Schultz ML; Tran BN; Jeziorek M; Kunkel TJ; Azaria RD; McLoughlin HS; Waghalter M; Xu Y; Schlame M; Altan-Bonnet N; Zheng W; Lieberman AP; Dobrowolski R; Storch J
J Biol Chem; 2021 Jul; 297(1):100813. PubMed ID: 34023384
[TBL] [Abstract][Full Text] [Related]
17. Impaired dynamics of the late endosome/lysosome compartment in human Niemann-Pick type C skin fibroblasts carrying mutation in NPC1 gene.
Sztolsztener ME; Dobrzyn A; Pikula S; Tylki-Szymanska A; Bandorowicz-Pikula J
Mol Biosyst; 2012 Apr; 8(4):1197-205. PubMed ID: 22286891
[TBL] [Abstract][Full Text] [Related]
18. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.
Praggastis M; Tortelli B; Zhang J; Fujiwara H; Sidhu R; Chacko A; Chen Z; Chung C; Lieberman AP; Sikora J; Davidson C; Walkley SU; Pipalia NH; Maxfield FR; Schaffer JE; Ory DS
J Neurosci; 2015 May; 35(21):8091-106. PubMed ID: 26019327
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts.
Cruz DL; Pipalia N; Mao S; Gadi D; Liu G; Grigalunas M; O'Neill M; Quinn TR; Kipper A; Ekebergh A; Dimmling A; Gartner C; Melancon BJ; Wagner FF; Holson E; Helquist P; Wiest O; Maxfield FR
ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1136-1148. PubMed ID: 34151204
[TBL] [Abstract][Full Text] [Related]
20. High-content screen for modifiers of Niemann-Pick type C disease in patient cells.
Pugach EK; Feltes M; Kaufman RJ; Ory DS; Bang AG
Hum Mol Genet; 2018 Jun; 27(12):2101-2112. PubMed ID: 29659804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]